✦ LIBER ✦

A Phase III, Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicentre Study to Assess the Efficacy and Safety of the β3 Adrenoceptor Agonist, Mirabegron, in Patients With Symptoms of Overactive Bladder

✍ Scribed by Herschorn, Sender; Barkin, Jack; Castro-Diaz, David; Frankel, Jeffrey M.; Espuna-Pons, Montserrat; Gousse, Angelo E.; Stölzel, Matthias; Martin, Nancy; Gunther, Adrie; Van Kerrebroeck, Philip

Book ID: 122732431
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 407 KB
Volume: 82
Category: Article
ISSN: 0090-4295
DOI: 10.1016/j.urology.2013.02.077

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized Double-blind, Active-controll

Randomized Double-blind, Active-controlled Phase 3 Study to Assess 12-Month Safety and Efficacy of Mirabegron, a β3-Adrenoceptor Agonist, in Overactive Bladder

✍ Christopher R. Chapple; Steven A. Kaplan; David Mitcheson; Jiri Klecka; Jana Cum 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 508 KB

683 Randomised, double-blind, active-con

683 Randomised, double-blind, active-controlled phase III study to assess the long-term safety and efficacy of mirabegron in overactive bladder (OAB)

✍ C.R. Chapple; S. Kaplan; H.D. Mitcheson; J. Klecka; J. Cummings; T. Drogendijk; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Efficacy and safety of solifenacin succi

Efficacy and safety of solifenacin succinate 10 mg once Daily: A multicenter, phase III, randomized, double-blind, placebo-controlled, parallel-group trial in patients with overactive bladder

✍ Franklin Chu; Neila Smith; Takeshi Uchida 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 141 KB

A randomized double-blind placebo-contro

A randomized double-blind placebo-controlled multicentre study to explore the efficacy and safety of tamsulosin and tolterodine in women with overactive bladder syndrome

✍ Dudley Robinson; Linda Cardozo; Gerben Terpstra; John Bolodeoku; the Tamsulosin 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB

A Randomized, Double-Blind, Placebo-Cont

A Randomized, Double-Blind, Placebo-Controlled Parallel-Group Study to Assess the Efficacy and Safety of Nebivolol, a Novel β-Blocker, in Patients With Mild to Moderate Hypertension

✍ Robert J. Weiss; Michael A. Weber; Albert A. Carr; Will A. Sullivan 📂 Article 📅 2007 🏛 Le Jacq Communications, Inc. 🌐 English ⚖ 218 KB

Efficacy and safety of rotigotine in Jap

Efficacy and safety of rotigotine in Japanese patients with restless legs syndrome: a phase 3, multicenter, randomized, placebo-controlled, double-blind, parallel-group study

✍ Inoue, Yuichi; Shimizu, Tetsuo; Hirata, Koichi; Uchimura, Naohisa; Ishigooka, Ju 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 566 KB